PhiChem Corporation

XSEC:300398 Stock Report

Market Cap: CN¥14.6b

PhiChem Valuation

Is 300398 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of 300398 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Fair Value: 300398 (CN¥25.71) is trading above our estimate of fair value (CN¥11.03)

Significantly Below Fair Value: 300398 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300398?

Key metric: As 300398 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 300398. This is calculated by dividing 300398's market cap by their current earnings.
What is 300398's PE Ratio?
PE Ratio44x
EarningsCN¥331.61m
Market CapCN¥14.58b

Price to Earnings Ratio vs Peers

How does 300398's PE Ratio compare to its peers?

The above table shows the PE ratio for 300398 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average96x
300910 Xinxiang Richful Lube AdditiveLtd
22.5x23.10%CN¥17.9b
688603 Shanghai Skychem Technology
155.8x37.31%CN¥12.1b
688690 Suzhou Nanomicro Technology
73.1x29.02%CN¥10.9b
603601 Chongqing Zaisheng Technology
132.9x40.99%CN¥10.8b
300398 PhiChem
44x10.60%CN¥14.6b

Price-To-Earnings vs Peers: 300398 is good value based on its Price-To-Earnings Ratio (44x) compared to the peer average (96x).


Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data


Price to Earnings Ratio vs Industry

How does 300398's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
300398 44.0xIndustry Avg. 48.0xNo. of Companies32PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 300398 is good value based on its Price-To-Earnings Ratio (44x) compared to the CN Chemicals industry average (47.9x).


Price to Earnings Ratio vs Fair Ratio

What is 300398's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300398 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio44x
Fair PE Ratio22.4x

Price-To-Earnings vs Fair Ratio: 300398 is expensive based on its Price-To-Earnings Ratio (44x) compared to the estimated Fair Price-To-Earnings Ratio (22.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 300398 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥25.71
CN¥22.87
-11.05%
12.55%CN¥25.74CN¥20.00n/a2
Jan ’27CN¥22.41
CN¥22.87
+2.05%
12.55%CN¥25.74CN¥20.00n/a2
Dec ’26CN¥22.29
CN¥22.87
+2.60%
12.55%CN¥25.74CN¥20.00n/a2
Nov ’26CN¥23.47
CN¥22.87
-2.56%
12.55%CN¥25.74CN¥20.00n/a2
Oct ’26CN¥26.39
CN¥22.21
-15.84%
9.95%CN¥24.42CN¥20.00n/a2
Sep ’26CN¥24.39
CN¥22.21
-8.94%
9.95%CN¥24.42CN¥20.00n/a2
Aug ’26CN¥19.23
CN¥20.33
+5.69%
1.60%CN¥20.65CN¥20.00n/a2
Jul ’26CN¥19.95
CN¥20.33
+1.88%
1.60%CN¥20.65CN¥20.00n/a2
Jun ’26CN¥20.76
CN¥20.33
-2.10%
1.60%CN¥20.65CN¥20.00n/a2
May ’26CN¥17.67
CN¥20.33
+15.03%
1.60%CN¥20.65CN¥20.00n/a2
Apr ’26CN¥18.50
CN¥18.05
-2.43%
10.80%CN¥20.00CN¥16.10n/a2
Mar ’26CN¥15.65
CN¥18.05
+15.34%
10.80%CN¥20.00CN¥16.10n/a2
Feb ’26CN¥15.85
CN¥18.05
+13.88%
10.80%CN¥20.00CN¥16.10n/a2
Jan ’26CN¥15.76
CN¥18.05
+14.53%
10.80%CN¥20.00CN¥16.10CN¥22.412
Dec ’25CN¥18.60
CN¥18.05
-2.96%
10.80%CN¥20.00CN¥16.10CN¥22.292
Nov ’25CN¥14.82
CN¥18.05
+21.79%
10.80%CN¥20.00CN¥16.10CN¥23.472
Oct ’25CN¥14.37
CN¥15.70
+9.26%
27.39%CN¥20.00CN¥11.40CN¥26.392
Sep ’25CN¥11.34
CN¥15.70
+38.45%
27.39%CN¥20.00CN¥11.40CN¥24.392
Aug ’25CN¥12.45
CN¥16.21
+30.20%
23.38%CN¥20.00CN¥12.42CN¥19.232
Jul ’25CN¥12.91
CN¥16.21
+25.56%
23.38%CN¥20.00CN¥12.42CN¥19.952
Jun ’25CN¥12.08
CN¥16.21
+34.19%
23.38%CN¥20.00CN¥12.42CN¥20.762
May ’25CN¥11.92
CN¥17.65
+48.10%
21.00%CN¥20.54CN¥12.42CN¥17.673
Apr ’25CN¥12.32
CN¥18.85
+53.03%
10.69%CN¥20.54CN¥16.02CN¥18.503
Mar ’25CN¥13.61
CN¥18.85
+38.53%
10.69%CN¥20.54CN¥16.02CN¥15.653
Feb ’25CN¥11.26
CN¥18.85
+67.44%
10.69%CN¥20.54CN¥16.02CN¥15.853
Jan ’25CN¥15.76
CN¥18.85
+19.63%
10.69%CN¥20.54CN¥16.02CN¥15.763
CN¥22.87
Fair Value
12.4% overvalued intrinsic discount
2
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/16 18:54
End of Day Share Price 2026/01/16 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PhiChem Corporation is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiongwei JiaChina International Capital Corporation Limited
Kai LiuEverbright Securities Co. Ltd.
Wei LiuHaitong International Research Limited